Merck & Co traded at $92.64 this Tuesday July 5th, increasing $0.22 or 0.24 percent since the previous trading session. Looking back, over the last four weeks, Merck & Co gained 3.12 percent. Over the last 12 months, its price rose by 18.60 percent. Looking ahead, we forecast Merck & Co to be priced at 89.92 by the end of this quarter and at 82.80 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
92.64
Daily Change
0.24%
Yearly
18.60%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 153.93 0.13 0.08% 33.01%
Abbott 109.30 -0.92 -0.83% -8.01%
ALKERMES 31.43 0.90 2.95% 22.97%
Amgen 246.73 1.18 0.48% 1.26%
AstraZeneca 10,800.00 -8.00 -0.07% 23.84%
Astrazeneca 65.51 -0.44 -0.67% 9.37%
Biogen 212.58 1.95 0.93% -38.36%
Bristol-Myers Squibb 75.96 -0.88 -1.15% 13.97%
Coherus Biosciences 8.54 0.71 9.07% -37.34%
Catalent 105.99 -1.03 -0.96% -6.33%
Endo International 0.52 -0.05 -8.79% -88.21%
Gilead Sciences 62.34 -0.02 -0.03% -8.87%
GlaxoSmithKline 1,786.60 -16.00 -0.89% 24.57%
Glaxosmithkline 43.30 -0.45 -1.03% 8.09%
Horizon Pharma 82.76 1.92 2.38% -13.59%
Intercept Pharmaceuticals 15.15 1.02 7.22% -20.43%
Jazz Pharmaceuticals 160.04 1.46 0.92% -12.51%
J&J 178.14 -1.38 -0.77% 6.05%
Eli Lilly 327.18 2.47 0.76% 38.98%
Medtronic 90.49 -0.89 -0.97% -28.73%
Merck & Co 92.64 0.22 0.24% 18.60%
Novartis 80.91 -0.74 -0.91% -4.31%
Novartis 84.28 -0.08 -0.09% -7.97%
Phibro Animal Health 20.15 0.56 2.86% -29.99%
Prestige Brands 59.78 0.20 0.34% 15.43%
Pacira 58.35 0.50 0.86% 1.23%
Pfizer 51.64 -0.67 -1.28% 31.43%
Perrigo 40.80 -0.22 -0.54% -13.01%
Drreddys Laboratories 55.87 0.03 0.05% -24.86%
Regeneron Pharmaceuticals 596.56 1.16 0.19% 2.46%
Roche Holding 319.00 -3.60 -1.12% -9.76%
Revance Therapeutics 14.73 0.40 2.79% -54.04%
Sanofi 97.12 -1.22 -1.24% 11.93%
Sanofi 50.18 -0.83 -1.63% -2.43%
Teva Pharmaceutical Industries 7.71 -0.18 -2.28% -19.77%
United Therapeutics 237.15 -0.85 -0.36% 28.00%
Zoetis 174.25 0.04 0.02% -10.19%

Indexes Price Day Year
US500 3834 6.06 0.16% -11.73%
US30 30952 -26.98 -0.09% -10.48%

Merck & Co
Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through two segments: Pharmaceutical and Animal Health. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations. The Animal Health segment develops, manufactures and markets a wide range of veterinary pharmaceutical and vaccine products, as well as health management solutions and services, for the prevention, treatment and control of disease in all major livestock and companion animal species.